Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

18th Nov 2009 10:03

RNS Number : 6869C
Immunodiagnostic Systems Hldgs PLC
18 November 2009
 



Immunodiagnostic Systems Holdings plc

Appointment of Non-Executive Director

Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of diagnostic testing kits for the clinical and research markets, announces the appointment of Dr. Burkhard Wittek as a Non-Executive Director with effect from 20 October 2009.

Dr. Wittekaged 56, holds an MBA from Harvard Business School. After working for Dresdner Bank AG he spent thirteen years with The Boston Consulting Group where he was a senior partner with worldwide responsibility for the consumer goods / retail and healthcare sectors. In 1990 he founded FORUM Family Office which makes long-term investments in German Private Equity and European Small and Midcap situations.

David Evans, Chairman of IDS, said, "We are very pleased to appoint Burkhard to the Board. Burkhard's  extensive knowledge and experience in the diagnostic sector will be a great asset for IDS as it continues to grow and he will no doubt provide a new and refreshing input to the Board's discussions. Burkhard has long recognised the growth potential of IDS, with Forum Venture Capital GmbH having become an investor in 2007 and now owning nearly 25% of the Company, and we welcome his continued support.

Aim Rules Disclosures:

Current Directorships

Previous Directorships (last five years)

FORUM Group

IonGen AG

Pulsion Medical Systems AG

Dr. Wittek was Chairman of Novaspin AG a start-up company which was placed into administration on 21 October 2002 due to a lack of funding.

There are no further matters in connection with the appointment of Dr. Wittek to be disclosed under Schedule Two, paragraph (g) of the AIM Rules.

ENDS

Enquiries:

Immunodiagnostic Systems Holdings Plc

Tel: 0191 519 0660

Roger Duggan, CEO

Paul Hailes, Finance Director

Brewin Dolphin Investment Banking

Tel: 0845 213 4730

Andrew Emmott

Sean Wyndham-Quin

Walbrook PR Ltd

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

[email protected]

Ben Knowles

Mob: 07900 346 978

[email protected]

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGGAGUPBUBR

Related Shares:

IDH.L
FTSE 100 Latest
Value8,447.57
Change30.23